Northern Biologics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

Northern Biologics General Information

Description

Developer of therapeutic antibodies intended to modify the tumor microenvironment in targeted patient populations. The company's therapeutic antibodies use antibody repertoires to develop functional modulators of key signaling pathways in cancer and fibrosis, enabling patients to get personalized cancer treatments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Acquirer
Boehringer Ingelheim
Corporate Office
  • 101 College Street
  • TMDT 11-301
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Northern Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 14-May-2020 0000 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B) 15-Jun-2019 0000 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series A) 15-Jun-2016 0000 Completed Clinical Trials - Phase 1
3. Early Stage VC 29-Apr-2015 0000 0000 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 01-Oct-2014 $10M $10M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 01-Jun-2014 Completed Clinical Trials - Phase 1
To view Northern Biologics’s complete valuation and funding history, request access »

Northern Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic antibodies intended to modify the tumor microenvironment in targeted patient populations. The c
Drug Discovery
Toronto, Canada
21 As of 2020
0000
000000&0 0000

000000

psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididu
0000 000000000
Middleton, WI
00 As of 0000
000.00
0000000000 0 000.00

000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
Gaithersburg, MD
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Northern Biologics Competitors (101)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrose Venture Capital-Backed Middleton, WI 00 000.00 0000000000 0 000.00
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Cogent Biosciences Formerly VC-backed Waltham, MA 000 00000 000000000 00000
Iovance Biotherapeutics Corporation San Carlos, CA 000 00000 00000000 00000
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands 0 000.00 00000 00000 000.00
You’re viewing 5 of 101 competitors. Get the full list »

Northern Biologics Patents

Northern Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11390670-B2 Antibodies against lif and uses thereof Active 03-Mar-2017 000000000000 00
US-20190352389-A1 Antibodies against lif and uses thereof Active 03-Mar-2017 000000000

Northern Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northern Biologics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blueline Bioscience Accelerator/Incubator Minority 000 0000 000000 0
Caixa Capital Risc Venture Capital Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
Northleaf Capital Partners Limited Partner Minority 000 0000 000000 0
Sixty Degree Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Northern Biologics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mosaic Biomedicals 19-Dec-2016 0000000000 Other Healthcare Services
To view Northern Biologics’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »